NCT06273878View on ClinicalTrials.gov

From Fetal-maternal Interface Immune Tolerance to Endometrial Cancer Immune Escape: Potential Targets for Immunotherapy

RecruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

January 15, 2023

Primary Completion Date

January 15, 2025

Study Completion Date

January 15, 2025

Conditions
Endometrial Cancer
Trial Locations (2)

00144

RECRUITING

National Cancer Institute - IFO -, Rome

RECRUITING

"Regina Elena National Cancer Institute", Rome

All Listed Sponsors
collaborator

Università degli Studi dell'Insubria

OTHER

lead

Regina Elena Cancer Institute

OTHER